399 related articles for article (PubMed ID: 24189526)
1. Metformin: do we finally have an anti-aging drug?
Anisimov VN
Cell Cycle; 2013 Nov; 12(22):3483-9. PubMed ID: 24189526
[TBL] [Abstract][Full Text] [Related]
2. Metformin for aging and cancer prevention.
Anisimov VN
Aging (Albany NY); 2010 Nov; 2(11):760-74. PubMed ID: 21084729
[TBL] [Abstract][Full Text] [Related]
3. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.
Anisimov VN; Bartke A
Crit Rev Oncol Hematol; 2013 Sep; 87(3):201-23. PubMed ID: 23434537
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens.
Anisimov VN; Berstein LM; Popovich IG; Zabezhinski MA; Egormin PA; Tyndyk ML; Anikin IV; Semenchenko AV; Yashin AI
Ann N Y Acad Sci; 2005 Dec; 1057():220-34. PubMed ID: 16399897
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
6. [Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect].
Anisimov VN
Ross Fiziol Zh Im I M Sechenova; 2008 Sep; 94(9):1092-109. PubMed ID: 18953996
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin.
Anisimov VN; Popovich IG; Zabezhinski MA; Egormin PA; Yurova MN; Semenchenko AV; Tyndyk ML; Panchenko AV; Trashkov AP; Vasiliev AG; Khaitsev NV
Cell Cycle; 2015; 14(1):46-55. PubMed ID: 25483062
[TBL] [Abstract][Full Text] [Related]
8. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention.
Anisimov VN
Exp Gerontol; 2003 Oct; 38(10):1041-9. PubMed ID: 14580857
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.
Anisimov VN; Piskunova TS; Popovich IG; Zabezhinski MA; Tyndyk ML; Egormin PA; Yurova MV; Rosenfeld SV; Semenchenko AV; Kovalenko IG; Poroshina TE; Berstein LM
Aging (Albany NY); 2010 Dec; 2(12):945-58. PubMed ID: 21164223
[TBL] [Abstract][Full Text] [Related]
10. Metformin slows down aging and extends life span of female SHR mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Tyndyk ML; Yurova MV; Kovalenko IG; Poroshina TE; Semenchenko AV
Cell Cycle; 2008 Sep; 7(17):2769-73. PubMed ID: 18728386
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
Gallagher EJ; LeRoith D
Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
[TBL] [Abstract][Full Text] [Related]
12. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
13. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.
Anisimov VN; Berstein LM; Popovich IG; Zabezhinski MA; Egormin PA; Piskunova TS; Semenchenko AV; Tyndyk ML; Yurova MN; Kovalenko IG; Poroshina TE
Aging (Albany NY); 2011 Feb; 3(2):148-57. PubMed ID: 21386129
[TBL] [Abstract][Full Text] [Related]
14. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
15. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.
Cabreiro F; Au C; Leung KY; Vergara-Irigaray N; Cochemé HM; Noori T; Weinkove D; Schuster E; Greene ND; Gems D
Cell; 2013 Mar; 153(1):228-39. PubMed ID: 23540700
[TBL] [Abstract][Full Text] [Related]
16. Caloric restriction in primates and relevance to humans.
Roth GS; Ingram DK; Lane MA
Ann N Y Acad Sci; 2001 Apr; 928():305-15. PubMed ID: 11795522
[TBL] [Abstract][Full Text] [Related]
17. A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan.
Mohammed I; Hollenberg MD; Ding H; Triggle CR
Front Endocrinol (Lausanne); 2021; 12():718942. PubMed ID: 34421827
[TBL] [Abstract][Full Text] [Related]
18. Metformin in obesity, cancer and aging: addressing controversies.
Berstein LM
Aging (Albany NY); 2012 May; 4(5):320-9. PubMed ID: 22589237
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1.
Onken B; Driscoll M
PLoS One; 2010 Jan; 5(1):e8758. PubMed ID: 20090912
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice.
Reifsnyder PC; Flurkey K; Doty R; Calcutt NA; Koza RA; Harrison DE
Aging Cell; 2022 Sep; 21(9):e13666. PubMed ID: 35986566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
